Identification of Hepatic Lesions
NCT00307866
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
218
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatic Neoplasms
Interventions
PROCEDURE:
Resovist (BAY86-4884, SH U 555 A)
Sponsor
Bayer